Benzoate X receptor zinc-finger gene switches for drug-inducible regulation of transcription.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 458, doi. 10.1038/gt.2011.112
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2012 AND VI 19 AND IP 4
Results: 15
1
2
Radioiodine therapy of thyroid carcinoma following Pax-8 gene transfer.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 435, doi. 10.1038/gt.2011.110
- By:
- Publication type:
- Article
3
10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 392, doi. 10.1038/gt.2011.109
- By:
- Publication type:
- Article
4
A retroviral vector suitable for ultrasound image-guided gene delivery to mouse brain.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 396, doi. 10.1038/gt.2011.120
- By:
- Publication type:
- Article
5
Gene therapy in a murine model of methylmalonic acidemia using rAAV9-mediated gene delivery.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 385, doi. 10.1038/gt.2011.108
- By:
- Publication type:
- Article
6
AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 411, doi. 10.1038/gt.2011.119
- By:
- Publication type:
- Article
7
Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 365, doi. 10.1038/gt.2011.104
- By:
- Publication type:
- Article
8
Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 375, doi. 10.1038/gt.2011.105
- By:
- Publication type:
- Article
9
RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 463, doi. 10.1038/gt.2011.103
- By:
- Publication type:
- Article
10
Sustained correction of OTC deficiency in spf<sup> ash</sup> mice using optimized self-complementary AAV2/8 vectors.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 404, doi. 10.1038/gt.2011.111
- By:
- Publication type:
- Article
11
HPV-16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2 and wt AAV2 production.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 418, doi. 10.1038/gt.2011.115
- By:
- Publication type:
- Article
12
Encapsulated engineered myoblasts can cure Hurler syndrome: preclinical experiments in the mouse model.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 355, doi. 10.1038/gt.2011.94
- By:
- Publication type:
- Article
13
Rescue administration of a helper-dependent adenovirus vector with long-term efficacy in dogs with glycogen storage disease type Ia.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 443, doi. 10.1038/gt.2011.86
- By:
- Publication type:
- Article
14
Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 453, doi. 10.1038/gt.2011.106
- By:
- Publication type:
- Article
15
Epidermal growth factor improves lentivirus vector gene transfer into primary mouse hepatocytes.
- Published in:
- Gene Therapy, 2012, v. 19, n. 4, p. 425, doi. 10.1038/gt.2011.117
- By:
- Publication type:
- Article